New decisions and important test information have emerged regarding some essential medicines used in the treatment of diseases like acidity, fatty liver, constipation and sickle cell.

Acidity medicine

If you have acidity and you buy medicine directly from a medical store, this will no longer be the case. According to the new rule, medical stores will no longer be able to dispense acidity medicine without a doctor's advice or prescription. This requirement has been imposed by the Central Drug Standard Control Organization. It states that the acidity medicine Vonoprizin must only be sold with a doctor's prescription.  

CDSCO states that if someone experiences frequent acidity and has been taking medication for a long time, it's important to determine the cause. Long-term use of certain medications can lead to vitamin B12 and magnesium deficiencies. Some people may also experience other problems. This doesn't mean everyone taking medication will experience these problems. However, if daily or long-term medication is required, a doctor should be consulted.

Prescription is also necessary for diseases related to the stomach and intestines.

An important change has been announced regarding Vonoprazan, a drug used to treat acidity. This drug is already approved in India in 10 and 20 mg doses. It has now been stated that it will be sold in stores only on the basis of a doctor's prescription. A doctor's prescription will be required, especially for stomach and intestinal conditions. Further testing of the drug has been announced. Therefore, it is important to seek medical advice rather than taking it on your own.

These medicines are being tested for the treatment of fatty liver.

It's worth noting that new drugs are also being developed for the treatment of fatty liver. These include Efruxifirmin and Resmetirom. Phase 3 trials of Efruxifirmin are being pursued. This is for patients with liver fat, along with inflammation and liver damage. Phase 3 trials of Resmetirom with varying doses are also being discussed. The purpose of these trials is to assess the safety and effectiveness of the drug for patients.

New drug for constipation and stomach pain in the works

Chronic constipation, accompanied by abdominal pain and other symptoms, is called IBS-C. A medication called linaclotide is used to treat this condition. Its 72 and 145 microgram dosages are recommended for chronic constipation. Furthermore, trials have also shown promise for patients with constipation, along with abdominal pain and other symptoms, using a 290 microgram dosage.

Children will also be tested for sickle cell disease.

A drug called atavopivat, used to treat sickle cell disease, is also undergoing testing. Phase 3 trials have now been recommended to include children aged 6 to 12 years. Such trials assess the drug's safety and effectiveness in treating the disease. Therefore, it cannot yet be considered a standard treatment for all children. The drug should only be used with a doctor's advice.